ORBITS
LIVE

Serial Number

97716665

Owner

Deben, Christophe

Attorney

Clifford D. Hyra

Filing Date

Dec 14, 2022

Add to watchlist:

No watchlists yet
View on USPTO

ORBITS Trademark

Serial Number: 97716665

ORBITS is a trademark filed by Deben, Christophe on December 14, 2022. The trademark is classified under Class 9 (Computers & Electronics), Class 42 (Computer & Scientific). The application is currently pending registration.

Owner Contact Info

Deben, Christophe

Rubensstraat 69
Kontich 2550 , BE

Entity Type: 01

Trademark Details

Filing Date

December 14, 2022

Registration Date

Not Registered

Goods & Services

Downloadable Software as a Medical Device (SaMD) for use in studying and analyzing cancer models and for use as medical image processors; Downloadable medical software for use in drug screening, drug discovery, image processing, image analysis and image storage and for use in studying and analyzing cancer models; Downloadable medical imaging software for recording, monitoring, studying and analyzing cancer models; Downloadable medical and scientific analysis software for use in drug screening, drug discovery, image processing, image analysis and image storage and for use in studying and analyzing cancer models; Downloadable software for medical imaging, image analysis, image storage, image transfer, drug screening, testing of pharmaceuticals and drug development; Downloadable cloud computing software for medical imaging, image analysis, image storage, image transfer, drug screening, testing of pharmaceuticals and drug development; Downloadable computer software platforms for medical imaging, image analysis, image storage, image transfer, drug screening, testing of pharmaceuticals and drug development; Downloadable software for analyzing microscopic images; Downloadable cloud computing software for analyzing microscopic images; Downloadable computer software platforms for analysing microscopic images; All the aforesaid in particular in the field of cancer research, cancer screening, cancer treatment and cancer diagnosis

Providing online, non-downloadable software for use as a medical device for image processing and for studying and analyzing cancer models; Platform as a Service (PAAS) featuring computer software platforms for medical imaging, image analysis, image storage, image transfer, drug screening, testing of pharmaceuticals and drug development; Cloud computing featuring software for use in medical imaging, image analysis, image storage, image transfer, drug screening, testing of pharmaceuticals and drug development; Providing temporary use of on-line non-downloadable cloud computing software for medical imaging, image analysis, image storage, image transfer, drug screening, testing of pharmaceuticals and drug development; Providing on-line non-downloadable software for medical imaging, image analysis, image storage, image transfer, drug screening, testing of pharmaceuticals and drug development; Software as a service (SAAS) services featuring software for medical imaging, image analysis, image storage and image transfer; Software as a service (SAAS) services featuring software for drug screening, testing of pharmaceuticals and drug development; Platform as a Service (PAAS) featuring computer software platforms for analyzing microscopic images; Cloud computing featuring software for use in analysing microscopic images; Providing temporary use of on-line on-downloadable cloud computing software for analysing microscopic images; Providing on-line non-downloadable software for analyzing microscopic images; Software as a service (SAAS) services featuring software for analyzing microscopic images; medical research laboratory services; Medical and scientific research in the field of medical imaging, image analysis, drug screening, testing of pharmaceuticals and drug development; Drug screening for scientific research purposes; Testing of pharmaceuticals; Drug discovery services; Pharmaceutical drug development services; Medical and scientific research, namely, conducting clinical trials for others; All the aforesaid also using artificial intelligence; All the aforesaid in particular in the field of cancer research, cancer screening, cancer treatment and cancer diagnosis

Filing History

REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Jan 2, 2025 RCSC
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Feb 2, 2024 GNS3
LETTER OF SUSPENSION E-MAILED
Feb 2, 2024 GNSL
SUSPENSION LETTER WRITTEN
Feb 2, 2024 CNSL
EXAMINER'S AMENDMENT ENTERED
Jan 16, 2024 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jan 16, 2024 GNEN
EXAMINERS AMENDMENT E-MAILED
Jan 16, 2024 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jan 16, 2024 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 11, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 11, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 11, 2023 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sep 21, 2023 GNRN
NON-FINAL ACTION E-MAILED
Sep 21, 2023 GNRT
NON-FINAL ACTION WRITTEN
Sep 21, 2023 CNRT
ASSIGNED TO EXAMINER
Sep 18, 2023 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 10, 2023 NWOS
NEW APPLICATION ENTERED
Dec 17, 2022 NWAP